Multidisciplinary Care for Anaplastic Thyroid Cancer-End-of-Life Care as a Standard of Care

By sjmartinez • May 10, 2025

Chen H, Evans L, Schaaff C, Labib M, Oh E, Ashendouek M, Sajed D, Ho WC, Wong DJ, Martin EJ, St John M. Multidisciplinary Care for Anaplastic Thyroid Cancer-End-of-Life Care as a Standard of Care. Laryngoscope. 2025 May 8. doi: 10.1002/lary.32243. Epub ahead of print. PMID: 40342186.

Tags: anaplastic thyroid cancer, end‐of‐life care, goals of care, Hematology/Oncology, hospice, Hospitalist, palliative care, Publications, Pulmonary, Critical Care & Sleep Medicine, targeted therapy

Rucaparib for maintenance treatment of platinum-sensitive, recurrent ovarian carcinoma: Final results of the phase 3, randomized, placebo-controlled ARIEL3 trial

Ledermann JA, Oza AM, Lorusso D, Aghajanian C, Oaknin A, Dean A, Colombo N, Weberpals JI, Clamp AR, Scambia G, Leary A, Holloway RW, Gancedo[...]

A bedside-to-bench translational analysis of NF1 alterations and CDK4/6 inhibitor resistance in hormone receptor-positive metastatic breast cancer

Lloyd MR, Chica-Parrado R, Weipert CM, Knepper TC, Podany EL, Napolitano F, Ye D, Lin CC, Uemoto Y, Liao J, Wegrzyn C, Walko CM, Ryan[...]

Finetuning Type I Interferon Signaling to Enhance T Cell Immunity in HIV Infection

Mu W, Kedia N, Zhen A. Finetuning Type I Interferon Signaling to Enhance T Cell Immunity in HIV Infection. Viruses. 2025 May 29;17(6):774. doi: 10.3390/v17060774.[...]